Wrist or Groin Angiography? Radial Versus Femoral Access

Is wrist or groin angiography more appropriate?

When feasible, radial access is preferred because randomised trials and guidelines show the most consistent benefit for access-site bleeding and vascular complications. A mortality benefit has not been shown at the same size in every trial. Access choice still depends on operator experience, anatomy and clinical status.

What is “wrist” (radial) angiography?

“Wrist angiography” is everyday language for transradial access: usually entry through the radial artery at the wrist. “From the arm” does not always mean upper-arm puncture; most procedures use the wrist radial artery. Under local anaesthesia a small sheath is placed; catheters are advanced to the aorta and coronary ostia; contrast images the arteries. When suitable, PCI / stenting can use the same access.

What is groin (femoral) angiography?

Transfemoral access uses the femoral artery in the groin. Under local anaesthesia catheters are advanced to the aorta and coronary arteries. After the procedure, manual compression or, in suitable patients, a vascular closure device may be used. Bed rest and movement limits depend on sheath size, medicines, closure method and clinical status. There is no fixed-hour guarantee.

Which method do current guidelines prefer?

In the 2024 ESC chronic coronary syndromes guideline, radial access is the standard access for coronary angiography when possible; it reduces major bleeding risk and allows faster mobilisation. Femoral diagnostic catheterisation is linked with more access-site complications.

In the 2023 ESC ACS guideline, radial access is preferred for invasive assessment ± PCI; access-site bleeding, vascular complications and need for transfusion / surgical repair may fall. Femoral access may still be chosen for haemodynamic or technical reasons.

In the 2021 ACC/AHA/SCAI revascularization guideline, radial access is preferred over femoral for PCI in ACS to reduce death, vascular complications or bleeding (Class I, Level A). For PCI in stable ischaemic heart disease, radial access is also recommended to reduce access-site bleeding and vascular complications (Class I, Level A). Operator experience, anatomy and selected clinical situations can change the preference.

What are the advantages of radial angiography?

Advantages include lower access-site bleeding; fewer large haematoma and pseudoaneurysm events; earlier mobilisation; a more comfortable recovery for many patients; and particular relevance in ACS patients on antithrombotic therapy. Claims such as “painless,” “risk-free” or “home the same day for sure” are not appropriate. Discharge depends on diagnostic versus PCI status, ACS, kidney function and complications. Radial benefit may matter especially in some higher-bleeding-risk groups; categorical rules such as “radial mandatory in women” or “femoral never in older adults” are not used.

What are the risks of radial angiography?

Balanced risks include radial spasm, access-site haematoma, radial artery occlusion (RAO), uncommon vessel injury, failed access with crossover to femoral, anatomical variation / tortuosity and small radial calibre. Hand ischaemia is rare; dual radial–ulnar supply means many RAOs cause no symptoms. RAO is still not trivial.

When may femoral angiography be preferred?

Femoral access is not a second-class method. It may be needed when radial access is impossible or fails; when the radial artery is too small, occluded or unsuitable; with certain anatomical challenges; when larger equipment is required for some complex procedures; when large-bore arterial access is needed for mechanical circulatory support; in selected haemodynamic emergencies; or by operator clinical/technical judgement. This is not an absolute indication list. Large-bore femoral techniques should not be confused with routine diagnostic coronary angiography. Access choice in complex anatomy is also discussed under bifurcation / LMCA interventions.

Why is bleeding risk often lower with radial access?

The radial artery is superficial, easier to compress and access-site bleeding usually stays local. The femoral artery is larger and deeper; haemostasis differs. That difference matters especially in ACS under intensive antithrombotic therapy. Antiplatelet duration and bleeding balance are covered in the medications after stenting and bleeding risk guide.

What did MATRIX show?

MATRIX Access compared radial versus femoral access in 8,404 patients with ACS undergoing invasive management. At 30 days, MACE was 8.8% vs 10.3%; because of the prespecified alpha, the MACE coprimary endpoint was not formally significant. Net adverse clinical events were 9.8% vs 11.7%; BARC major non-CABG bleeding 1.6% vs 2.3%; all-cause mortality 1.6% vs 2.2%. These results should not be told as “wrist angiography definitely reduces death.” The safest summary is that MATRIX supports a radial advantage in ACS especially for bleeding and net clinical events. One-year MATRIX results have been interpreted in the same direction.

What did RIVAL show?

In 7,021 ACS patients, RIVAL reported a 30-day composite of death / MI / stroke / non-CABG major bleeding of 3.7% with radial and 4.0% with femoral access (no significant difference). Death/MI/stroke was 3.2% vs 3.2%; non-CABG major bleeding 0.7% vs 0.9%. Large haematoma (42 vs 106) and pseudoaneurysm requiring closure (7 vs 23) were lower with radial access. It is incorrect to say radial was superior on all clinical endpoints; STEMI or high-volume radial-centre subgroups should not be presented as the main result.

Why are STEMI trial results not identical?

RIFLE-STEACS, in ST-elevation ACS, reported 30-day NACE of 13.6% radial vs 21.0% femoral; bleeding 7.8% vs 12.2%; cardiac mortality 5.2% vs 9.2%. It was run in experienced radial centres and should not alone be framed as “radial halves mortality.”

SAFARI-STEMI, in 2,292 STEMI patients, found 30-day all-cause mortality 1.5% radial vs 1.3% femoral and bleeding 1.4% vs 2.0% (no significant differences) and stopped early for futility. That does not mean “there is no radial advantage.” Mortality benefit has not been shown at the same size in every randomised trial; the most consistent basis for guideline preference remains lower access-site bleeding and vascular-complication risk.

What is radial artery occlusion?

Radial artery occlusion (RAO) is closure of the radial artery after the procedure. Risk relates to sheath-to-artery size ratio, procedural anticoagulation, patent haemostasis and avoiding unnecessarily long or excessive compression. There is no single fixed percentage; rates vary with sheath size and haemostasis protocol. SCAI and JACC consensus documents summarise RAO-prevention practices; this guide does not prescribe heparin doses.

What is patent haemostasis?

Patent haemostasis means applying enough wrist compression after the procedure to stop bleeding while, when possible, not completely abolishing radial-artery flow. The aim is to protect both haemostasis and radial patency. Patients are not instructed to loosen the band themselves.

When can patients get up after radial angiography?

A compression band may be applied at the wrist. Many patients can sit and walk earlier because groin haemostasis is not required. Band removal, observation time and discharge vary by centre and patient status. Marked coldness, colour change, escalating pain, rapidly expanding swelling/haematoma or ongoing bleeding needs clinical / urgent review.

Why may bed rest be needed after femoral angiography?

After femoral access, bed rest or movement restriction may be needed for bleeding control. Duration depends on sheath size, antithrombotic medicines, manual compression / closure device and clinical status. Rapidly expanding groin swelling, ongoing bleeding, marked leg coldness/pallor, severe groin or abdominal/back pain, and syncope / marked weakness are examples needing urgent assessment. Retroperitoneal bleeding is an uncommon but serious femoral complication and is noted without sensational detail.

Can the procedure switch from radial to femoral?

Yes. If radial access fails or is inadequate, crossover to femoral access may be used. That does not mean the procedure failed; it is chosen for safe completion.

Why does the radial artery matter if bypass is possible?

In the 2021 ACC/AHA/SCAI framework, the radial artery can be used as an arterial graft in coronary bypass surgery. When CABG is likely, whether to use the radial artery for catheterisation may be planned with cardiac surgery. It is incorrect to say “radial angiography prevents bypass”; using a radial artery for access does not automatically mean it cannot be used for CABG — vessel status is assessed clinically. Anatomical decision-making also relates to the LMCA / bifurcation stent-versus-bypass guide.

In brief: radial or femoral?

When technically feasible, radial / wrist access is preferred in current ESC and ACC/AHA/SCAI guidelines; the most consistent advantage is lower access-site bleeding and vascular complications. MATRIX and RIVAL support that framing; mortality advantage is not identical across STEMI trials (SAFARI-STEMI). Femoral access remains appropriate and sometimes necessary in selected patients. The route is chosen by person, anatomy and procedure.